PURPOSE: This work investigates a novel, naturally occurring mouse model of achromatopsia. The specific missense mutation within the Gnat2 gene was identified and the subsequent retinal phenotype characterized. METHODS: The Gnat2 sequence was amplified using PCR from BALB/c and Gnat2(c.518A>G) retinae and the product sequenced. Retinal function was assessed at 3, 6, 9, and 12 months using the electroretinogram. Transducin and opsin expression were assessed at 3 and 12 months using immunohistochemistry and quantitative PCR. Retinal remodeling and Müller cell gliosis were investigated using immunocytochemistry. RESULTS: An A to G missense mutation at position 518 of the Gnat2 gene was identified that resulted in an aspartic acid to glycine substitution. Gnat2(c.518A>G) animals showed no cone response, while the rod response was normal except for a decrease in the photoreceptor response at 12 months (a-wave, -14%). Gnat2(c.518A>G) retinal sections showed no transducin immunolabeling; however, protein was detected via Western blot. Gnat2 gene expression was only decreased at 12 months of age (-27%). There was reduced cone number at 12 months (-27%) and M-opsin showed evidence of mislocalization. Displaced photoreceptor terminals and altered horizontal cell, cone/rod bipolar cell morphology were evident at 3 months, becoming more extensive at 12 months with the emergence of Müller cell gliosis. CONCLUSIONS: The Gnat2(c.518A>G) mouse contains a missense mutation that results in no cone function due to a misfolding of transducin. Cone photoreceptors also show signs of opsin mislocalization, retinal remodeling and degeneration. This naturally occurring model shows all the hallmark signs of achromatopsia.
PURPOSE: This work investigates a novel, naturally occurring mouse model of achromatopsia. The specific missense mutation within the Gnat2 gene was identified and the subsequent retinal phenotype characterized. METHODS: The Gnat2 sequence was amplified using PCR from BALB/c and Gnat2(c.518A>G) retinae and the product sequenced. Retinal function was assessed at 3, 6, 9, and 12 months using the electroretinogram. Transducin and opsin expression were assessed at 3 and 12 months using immunohistochemistry and quantitative PCR. Retinal remodeling and Müller cell gliosis were investigated using immunocytochemistry. RESULTS: An A to G missense mutation at position 518 of the Gnat2 gene was identified that resulted in an aspartic acid to glycine substitution. Gnat2(c.518A>G) animals showed no cone response, while the rod response was normal except for a decrease in the photoreceptor response at 12 months (a-wave, -14%). Gnat2(c.518A>G) retinal sections showed no transducin immunolabeling; however, protein was detected via Western blot. Gnat2 gene expression was only decreased at 12 months of age (-27%). There was reduced cone number at 12 months (-27%) and M-opsin showed evidence of mislocalization. Displaced photoreceptor terminals and altered horizontal cell, cone/rod bipolar cell morphology were evident at 3 months, becoming more extensive at 12 months with the emergence of Müller cell gliosis. CONCLUSIONS: The Gnat2(c.518A>G) mouse contains a missense mutation that results in no cone function due to a misfolding of transducin. Cone photoreceptors also show signs of opsin mislocalization, retinal remodeling and degeneration. This naturally occurring model shows all the hallmark signs of achromatopsia.
Authors: Andrew I Jobling; Michelle Waugh; Kirstan A Vessey; Joanna A Phipps; Lidia Trogrlic; Una Greferath; Samuel A Mills; Zhi L Tan; Michelle M Ward; Erica L Fletcher Journal: J Neurosci Date: 2018-04-18 Impact factor: 6.167
Authors: Markus Burkard; Susanne Kohl; Timm Krätzig; Naoyuki Tanimoto; Christina Brennenstuhl; Anne E Bausch; Katrin Junger; Peggy Reuter; Vithiyanjali Sothilingam; Susanne C Beck; Gesine Huber; Xi-Qin Ding; Anja K Mayer; Britta Baumann; Nicole Weisschuh; Ditta Zobor; Gesa-Astrid Hahn; Ulrich Kellner; Sascha Venturelli; Elvir Becirovic; Peter Charbel Issa; Robert K Koenekoop; Günther Rudolph; John Heckenlively; Paul Sieving; Richard G Weleber; Christian Hamel; Xiangang Zong; Martin Biel; Robert Lukowski; Matthias W Seeliger; Stylianos Michalakis; Bernd Wissinger; Peter Ruth Journal: J Clin Invest Date: 2018-11-12 Impact factor: 19.456
Authors: Naoto Tanaka; Emily V Dutrow; Keiko Miyadera; Lucie Delemotte; Christopher M MacDermaid; Shelby L Reinstein; William R Crumley; Christopher J Dixon; Margret L Casal; Michael L Klein; Gustavo D Aguirre; Jacqueline C Tanaka; Karina E Guziewicz Journal: PLoS One Date: 2015-09-25 Impact factor: 3.240
Authors: Kirstan A Vessey; Ursula Greferath; Felix P Aplin; Andrew I Jobling; Joanna A Phipps; Tracy Ho; Robbert U De Iongh; Erica L Fletcher Journal: J Comp Neurol Date: 2014-04-03 Impact factor: 3.215
Authors: Ursula Greferath; Kirstan A Vessey; Andrew I Jobling; Samuel A Mills; Bang V Bui; Zheng He; Nupur Nag; Hiroshi Ohtsu; Erica L Fletcher Journal: PLoS One Date: 2014-12-29 Impact factor: 3.240
Authors: Ulrich F O Luhmann; Livia S Carvalho; Sophia-Martha Kleine Holthaus; Jill A Cowing; Simon Greenaway; Colin J Chu; Philipp Herrmann; Alexander J Smith; Peter M G Munro; Paul Potter; James W B Bainbridge; Robin R Ali Journal: Hum Mol Genet Date: 2014-08-21 Impact factor: 6.150
Authors: Gayle B Collin; Navdeep Gogna; Bo Chang; Nattaya Damkham; Jai Pinkney; Lillian F Hyde; Lisa Stone; Jürgen K Naggert; Patsy M Nishina; Mark P Krebs Journal: Cells Date: 2020-04-10 Impact factor: 7.666